You have reached the TARGAXAN® (rifaximin-α) website which is intended for UK healthcare professionals and has been developed by Norgine to provide you with information about the product.
Please select an option below:
Adverse events should be reported. Reporting forms and information can be found at (United Kingdom) or (Ireland)

Adverse events should also be reported to Medical Information at Norgine Pharmaceuticals Ltd on 01895 826606 or Email:

Product under licence from Alfasigma S.p.A. TARGAXAN is a registered trademark of the Alfasigma group of companies, licensed to the Norgine group of companies

NORGINE and the sail logo are registered trademarks of the Norgine group of companies

Date of preparation: May 2020 Job Code: UKE-HEP-XIF-2000012 © 2019 Norgine

Privacy Policy